• Exchange: Stuttgart
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Optimer Pharmaceuticals Inc

+ Add to Watchlist


Price not available for XYH:GR

Snapshot for Optimer Pharmaceuticals Inc (XYH)

Open: - Day's Range: - Volume: 0
Previous Close: 9.188 52wk Range: - 1-Yr Rtn: -

Stock Chart for XYH

No chart data available.
  • XYH:GR 9.188
  • 1M
  • 1Y
Interactive XYH Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for XYH

Current P/E Ratio (ttm) -
Estimated P/E(12/2013) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2013) -2.1070
Est. PEG Ratio -
Market Cap (M EUR) 0.00
Shares Outstanding (M) 0.00
30 Day Average Volume -
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement -
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for XYH

No data available

Company Profile & Key Executives for XYH

Optimer Pharmaceuticals, Inc. discovers, develops, and commercializes anti infective products. Optimer's initial development efforts address products that treat gastrointestinal infections (GI), and related diseases, including diminished efficacy, serious adverse side effects, drug-to-drug interactions, difficult patient compliance, and bacterial resistance.

Eric SirotaChief Operating OfficerMeredith SchaumChief Compliance Ofcr/Gen Cnsl
Sherwood L GorbachSenior VP/Chief Scientific OfcrLinda E AmperSenior VP:Human Resources
More Company Profile & Key Executives for XYH

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil